Capmatinib, 10mM/1mL

Capmatinib, 10mM/1mL

Tofacitinib, 5mg

Tofacitinib, 5mg

Capmatinib, 200mg

9.688,98 RON
SKU
SKM_S2788_200mg

Capmatinib is a novel, ATP-competitive inhibitor of c-METwith IC50of 0.13 nM in a cell-free assay, inactive against RONβ, as well as EGFR and HER-3. Capmatinib (INCB28060) inhibits Wnt/β-cateninand EMT signaling pathways and induces apoptosisin diffuse gastric cancer positive for c-MET amplification. Phase 1.

Mai multe informatii
Price 8.142,00 RON (preturile sunt fara TVA)
Description

Capmatinib is a novel, ATP-competitive inhibitor of c-METwith IC50of 0.13 nM in a cell-free assay, inactive against RONβ, as well as EGFR and HER-3. Capmatinib (INCB28060) inhibits Wnt/β-cateninand EMT signaling pathways and induces apoptosisin diffuse gastric cancer positive for c-MET amplification. Phase 1.